Thrombotic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Thrombotic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura [Phase 3]
A Phase 3 study evaluating TAK-755 for congenital thrombotic thrombocytopenic purpura is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura [Phase 3]
Phase 3 trial evaluating caplacizumab in combination with immunosuppressive therapy without first-line therapeutic plasma exchange in adults…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP) [Phase 3]
This Phase 3 study of BAX 930 in children, teenagers, and adults with thrombotic thrombocytopenic purpura has completed and results have bee…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP) [Phase 2]
This Phase 2 safety study evaluating danazol in combination with plasma exchange and steroids for thrombotic thrombocytopenic purpura was te…
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP) [Phase 2]
Phase 2 trial update examining the use of rituximab in acute thrombotic thrombocytopenic purpura (TTP) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP) [Phase 3]
Phase 3 trial evaluating cyclosporine or corticosteroids as adjuncts to plasma exchange in thrombotic thrombocytopenic purpura has completed…
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Aspirin for Prophylaxis of TTP [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating aspirin for prophylaxis of thrombotic thrombocytopenic purpura is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care [Phase 3]
Phase 3 trial update investigating magnesium sulfate for thrombotic thrombocytopenic purpura in intensive care.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura [Phase 2]
Phase 2 clinical trial evaluating low-dose rituximab for thrombotic thrombocytopenic purpura has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia [Phase 2]
Phase 2 trial evaluating romiplostim, rituximab, and dexamethasone as frontline treatment for immune thrombocytopenia and thrombotic thrombo…
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients [Phase 2]
Phase 2 trial update for IdeS in asymptomatic antibody-mediated thrombotic thrombocytopenic purpura (TTP) has been terminated; results poste…
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP) [Phase 3]
Phase 3 trial comparing Uniplas with Cryosupernatant Plasma in thrombotic thrombocytopenic purpura was terminated.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura [Phase 2]
This update reports the completion of a Phase 2 trial evaluating rituximab for adult acquired idiopathic thrombotic thrombocytopenic purpura…
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) [Phase 3]
A Phase 3 trial evaluating the addition of rituximab to standard therapy for thrombotic thrombocytopenic purpura was terminated, with result…
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: ADAMTS13 in Thrombotic Thrombocytopenic Purpura
The clinical trial investigating ADAMTS13 for thrombotic thrombocytopenic purpura has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-19Clinical Trial Update: Rituximab in Patients With Relapsed or Refractory TTP-HUS [Phase 2]
Phase 2 trial evaluating rituximab in patients with relapsed or refractory thrombotic thrombocytopenic purpura and hemolytic uremic syndrome…
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy [Phase 2]
A Phase 2 clinical trial evaluating ARC1779 for thrombotic microangiopathy was terminated.
-
CLINICAL_TRIALS trial_result · 2009-01-09Clinical Trial Update: ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders [Phase 2]
Phase 2 clinical trial update for ARC1779 injection in patients with von Willebrand factor-related platelet function disorders; the study st…